NDCFind

Margenza 70720-0022

Generic: Margetuximab-Cmkb

Product NDC

70720-0022
Manufacturer
Tersera Therapeutics Llc
Dosage Form
Injection, Solution, Concentrate
Route
Intravenous
Product Type
Human Prescription Drug
Marketing Start
January 15, 2021
Listing Expires
December 31, 2026
Application
BLA761150
StockMeds — pharmacy-to-pharmacy marketplace

Need to source Margenza? P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

IngredientStrength
Margetuximab25 mg/mL

Drug Class

HER2/neu Receptor Antagonist [EPC]HER2/Neu/cerbB2 Antagonists [MoA]HER2/neu Receptor Antagonist [EPC]